The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea

H. R. Chowdhury, M. Yunus, K. Zaman, A. Rahman, S. M. Faruque, A. G. Lescano, R. B. Sack

Research output: Contribution to journalArticle

Abstract

A controlled, randomized, double-blind study in Bangladeshi children (ages 4-36 mo) with acute diarrhoea was undertaken to determine whether bismuth subsalicylate (BSS) would prevent the development of persistent diarrhoea (PD) in young children. The children were randomized to two groups: 226 were given liquid oral BSS, (as Pepto-Bismol), 100 mg/kg/d for 5 d; 225 were given placebo of identical appearance. On admission to the study, the two groups were comparable both clinically and microbiologically. Rotavirus was found in 56% of all the children, and enterotoxigenic E. coli in 31% of a subsample studied. Children treated with BSS had less severe and less prolonged illness than those treated with placebo (p = 0.057). There was, however, no difference in the development of PD between the two groups (8% and 11%). Unexpectedly, patients treated with BSS gained significantly more weight (2.3%) than those treated with placebo (0.5%; p <0.001) during the course of the study. No toxicity of BSS was detected. Conclusion: Treatment with BSS had a modest therapeutic effect on acute diarrhoea, as has been previously demonstrated, but with no suggestion of a therapeutic effect on the prevention of persistent diarrhoea in this group of patients.

Original languageEnglish (US)
Pages (from-to)605-610
Number of pages6
JournalActa Paediatrica, International Journal of Paediatrics
Volume90
Issue number6
StatePublished - 2001

Fingerprint

Diarrhea
Placebos
Therapeutic Uses
Therapeutics
Enterotoxigenic Escherichia coli
Rotavirus
bismuth subsalicylate
Double-Blind Method
Weights and Measures

Keywords

  • Acute diarrhoea
  • Bismuth subsalicylate
  • Nutrition
  • Persistent diarrhoea

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Chowdhury, H. R., Yunus, M., Zaman, K., Rahman, A., Faruque, S. M., Lescano, A. G., & Sack, R. B. (2001). The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea. Acta Paediatrica, International Journal of Paediatrics, 90(6), 605-610.

The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea. / Chowdhury, H. R.; Yunus, M.; Zaman, K.; Rahman, A.; Faruque, S. M.; Lescano, A. G.; Sack, R. B.

In: Acta Paediatrica, International Journal of Paediatrics, Vol. 90, No. 6, 2001, p. 605-610.

Research output: Contribution to journalArticle

Chowdhury, HR, Yunus, M, Zaman, K, Rahman, A, Faruque, SM, Lescano, AG & Sack, RB 2001, 'The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea', Acta Paediatrica, International Journal of Paediatrics, vol. 90, no. 6, pp. 605-610.
Chowdhury, H. R. ; Yunus, M. ; Zaman, K. ; Rahman, A. ; Faruque, S. M. ; Lescano, A. G. ; Sack, R. B. / The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea. In: Acta Paediatrica, International Journal of Paediatrics. 2001 ; Vol. 90, No. 6. pp. 605-610.
@article{b9cf7f1ec32a4f6b8d2e61e81a387bab,
title = "The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea",
abstract = "A controlled, randomized, double-blind study in Bangladeshi children (ages 4-36 mo) with acute diarrhoea was undertaken to determine whether bismuth subsalicylate (BSS) would prevent the development of persistent diarrhoea (PD) in young children. The children were randomized to two groups: 226 were given liquid oral BSS, (as Pepto-Bismol), 100 mg/kg/d for 5 d; 225 were given placebo of identical appearance. On admission to the study, the two groups were comparable both clinically and microbiologically. Rotavirus was found in 56{\%} of all the children, and enterotoxigenic E. coli in 31{\%} of a subsample studied. Children treated with BSS had less severe and less prolonged illness than those treated with placebo (p = 0.057). There was, however, no difference in the development of PD between the two groups (8{\%} and 11{\%}). Unexpectedly, patients treated with BSS gained significantly more weight (2.3{\%}) than those treated with placebo (0.5{\%}; p <0.001) during the course of the study. No toxicity of BSS was detected. Conclusion: Treatment with BSS had a modest therapeutic effect on acute diarrhoea, as has been previously demonstrated, but with no suggestion of a therapeutic effect on the prevention of persistent diarrhoea in this group of patients.",
keywords = "Acute diarrhoea, Bismuth subsalicylate, Nutrition, Persistent diarrhoea",
author = "Chowdhury, {H. R.} and M. Yunus and K. Zaman and A. Rahman and Faruque, {S. M.} and Lescano, {A. G.} and Sack, {R. B.}",
year = "2001",
language = "English (US)",
volume = "90",
pages = "605--610",
journal = "Acta Paediatrica, International Journal of Paediatrics",
issn = "0803-5253",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - The efficacy of bismuth subsalicylate in the treatment of acute diarrhoea and the prevention of persistent diarrhoea

AU - Chowdhury, H. R.

AU - Yunus, M.

AU - Zaman, K.

AU - Rahman, A.

AU - Faruque, S. M.

AU - Lescano, A. G.

AU - Sack, R. B.

PY - 2001

Y1 - 2001

N2 - A controlled, randomized, double-blind study in Bangladeshi children (ages 4-36 mo) with acute diarrhoea was undertaken to determine whether bismuth subsalicylate (BSS) would prevent the development of persistent diarrhoea (PD) in young children. The children were randomized to two groups: 226 were given liquid oral BSS, (as Pepto-Bismol), 100 mg/kg/d for 5 d; 225 were given placebo of identical appearance. On admission to the study, the two groups were comparable both clinically and microbiologically. Rotavirus was found in 56% of all the children, and enterotoxigenic E. coli in 31% of a subsample studied. Children treated with BSS had less severe and less prolonged illness than those treated with placebo (p = 0.057). There was, however, no difference in the development of PD between the two groups (8% and 11%). Unexpectedly, patients treated with BSS gained significantly more weight (2.3%) than those treated with placebo (0.5%; p <0.001) during the course of the study. No toxicity of BSS was detected. Conclusion: Treatment with BSS had a modest therapeutic effect on acute diarrhoea, as has been previously demonstrated, but with no suggestion of a therapeutic effect on the prevention of persistent diarrhoea in this group of patients.

AB - A controlled, randomized, double-blind study in Bangladeshi children (ages 4-36 mo) with acute diarrhoea was undertaken to determine whether bismuth subsalicylate (BSS) would prevent the development of persistent diarrhoea (PD) in young children. The children were randomized to two groups: 226 were given liquid oral BSS, (as Pepto-Bismol), 100 mg/kg/d for 5 d; 225 were given placebo of identical appearance. On admission to the study, the two groups were comparable both clinically and microbiologically. Rotavirus was found in 56% of all the children, and enterotoxigenic E. coli in 31% of a subsample studied. Children treated with BSS had less severe and less prolonged illness than those treated with placebo (p = 0.057). There was, however, no difference in the development of PD between the two groups (8% and 11%). Unexpectedly, patients treated with BSS gained significantly more weight (2.3%) than those treated with placebo (0.5%; p <0.001) during the course of the study. No toxicity of BSS was detected. Conclusion: Treatment with BSS had a modest therapeutic effect on acute diarrhoea, as has been previously demonstrated, but with no suggestion of a therapeutic effect on the prevention of persistent diarrhoea in this group of patients.

KW - Acute diarrhoea

KW - Bismuth subsalicylate

KW - Nutrition

KW - Persistent diarrhoea

UR - http://www.scopus.com/inward/record.url?scp=0034956858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034956858&partnerID=8YFLogxK

M3 - Article

C2 - 11440090

AN - SCOPUS:0034956858

VL - 90

SP - 605

EP - 610

JO - Acta Paediatrica, International Journal of Paediatrics

JF - Acta Paediatrica, International Journal of Paediatrics

SN - 0803-5253

IS - 6

ER -